InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Wheeler Craig A, Director. Insider active across 4 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 10 disclosures have been logged. History available since 10 June 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wheeler Craig A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
24,444 股Common StockSEC:0001193125-26-224585:0
84,631 股@ US$14.500.026% mcap100.0% 占其流量Common StockSEC:0001193125-26-182285:0
7,961 股0Common StockSEC:0001492422-26-000008:0
20,414 股0Common StockSEC:0000950170-25-083196:0
16,483 股0Common StockSEC:0001127602-25-012384:0
11,847 股0Common StockSEC:0000950170-24-071009:0
8,584 股0Common StockSEC:0001209191-23-036412:0
12,671 股0Common StockSEC:0001209191-22-035857:0
10,115 股0Common StockSEC:0001209191-21-040379:0
63,000 股Common StockSEC:0001179110-16-018968:0
10 条申报中的 10 条
About Wheeler Craig A
Craig A. Wheeler is a Director at Apellis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. He brings expertise in management and business strategy to the boards. His role is essential in guiding strategic decisions and ensuring the sustainable growth of the companies.
